RecruitingNot ApplicableNCT06575673

An Internet-based Dialectical Behaviour Therapy-informed Skills Training for Promoting Smoking Cessation and Improving Psychological Distress of Adult Smokers.

Effect of an Internet-based Dialectical Behaviour Therapy-informed Skills Training for Promoting Smoking Cessation and Improving Psychological Distress of Smokers: A Pilot Randomised Controlled Trial


Sponsor

Chinese University of Hong Kong

Enrollment

60 participants

Start Date

Sep 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

1. To determine the feasibility, acceptability, and preliminary effects of an internet-based DBT-ST for promoting smoking abstinence/reduction and improving psychological distress/emotional regulation in adult smokers 2. To explore the participants' experiences and perceptions (e.g., perceived benefits/weaknesses) towards the proposed intervention


Eligibility

Min Age: 18 YearsMax Age: 64 Years

Inclusion Criteria5

  • Hong Kong Chinese aged 18-64 years
  • Had smoked at least one cigarette per day over the previous three months
  • Indicate psychological distress as measured by the Depression, Anxiety, and Stress Scale-21
  • Have an intention to stop smoking
  • Have an electronic device and are willing to receive interventions via the internet

Exclusion Criteria2

  • Experiencing psychotic disorders/cognitive impairment/communication problems
  • Participating in other smoking cessation programs or related psychosocial interventions

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALInternet-based dialectical behaviour therapy-informed skills training

Adaptive applications of DBT-ST for smokers with psychological distress

BEHAVIORALMonthly health education

General health information and sharing sessions


Locations(2)

Hospital Authority

Tai Po, New Territories, Hong Kong

Hospital Authority

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06575673


Related Trials